Gene therapy and wound healing

Clinics in Dermatology

Volumn 25, Issue 1, 2007, Pages 79-92

  Eming, Sabine A ^a   Krieg, Thomas ^a   Davidson, Jeffrey M ^b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH FACTOR;

ARTICLE; CELL FUNCTION; CELL TYPE; EXTRACELLULAR MATRIX; GENE THERAPY; GENE TRANSFER; PRIORITY JOURNAL; TISSUE REPAIR; WOUND HEALING;

GENE THERAPY; HUMANS; SKIN; SKIN ULCER; SOFT TISSUE INJURIES; WOUND HEALING; WOUNDS, PENETRATING;

EID: 33846608167     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2006.09.011     Document Type: Article

References (140)

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
2. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738-746
3. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83 (2003) 835-870
4. Lawrence W.T., and Diegelmann R.F. Growth factors in wound healing. Clin Dermatol 12 (1994) 157-169
5. Scharffetter-Kochanek K., Klein P., and Krieg T. Cellular and molecular mechanisms of tissue repair. Basic Res Cardiol 93 Suppl 3 (1998) 1-3
6. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 33 (2000) 94-101
7. Vacanti J.P., and Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354 Suppl 1 (1999) SI32-SI34
8. Korbling M., and Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept?. N Engl J Med 349 (2003) 570-582
9. Clark R.A. Cutaneous tissue repair: basic biologic considerations. I. J Am Acad Dermatol 13 (1985) 701-725
10. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
11. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
12. Smola H., Stark H.J., Thiekotter G., et al. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res 239 (1998) 399-410
13. Smola H., Thiekotter G., and Fusenig N.E. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122 (1993) 417-429
14. Scheid A., Meuli M., Gassmann M., et al. Genetically modified mouse models in studies on cutaneous wound healing. Exp Physiol 85 (2000) 687-704
15. Schroder J.M. Cytokine networks in the skin. J Invest Dermatol 105 (1995) 20S-24S
16. Gillitzer R., and Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 69 (2001) 513-521
17. Leibovich S.J., and Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 78 (1975) 71-100
18. Martin P., D'Souza D., Martin J., et al. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13 (2003) 1122-1128
19. Werner S., and Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 11 (2001) 143-146
20. Smiell J.M., Wieman T.J., Steed D.L., et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 7 (1999) 335-346
21. Ashcroft G.S., Lei K., Jin W., et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 6 (2000) 1147-1153
22. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 100 (1993) 721-725
23. Wenk J., Foitzik A., Achterberg V., et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 116 (2001) 833-839
24. Grinnell F., Ho C.H., and Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98 (1992) 410-416
25. Grinnell F., and Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 106 (1996) 335-341
26. Herouy Y., May A.E., Pornschlegel G., et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol 111 (1998) 822-827
27. Weckroth M., Vaheri A., Lauharanta J., et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106 (1996) 1119-1124
28. Lauer G., Sollberg S., Cole M., et al. Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site. FEBS Lett 531 (2002) 309-313
29. Wlaschek M., Peus D., Achterberg V., et al. Protease inhibitors protect growth factor activity in chronic wounds. Br J Dermatol 137 (1997) 646
30. Lauer G., Sollberg S., Cole M., et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 115 (2000) 12-18
31. Hoffman R., Starkey S., and Coad J. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes. J Invest Dermatol 111 (1998) 1140-1144
32. Wallace H.J., and Stacey M.C. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol 110 (1998) 292-296
33. Aepfelbacher M., Essler M., Huber E., et al. Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells. Arterioscler Thromb Vasc Biol 17 (1997) 1623-1629
34. Barbieri J.T. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin. Int J Med Microbiol 290 (2000) 381-387
35. Bowler P.G. Wound pathophysiology, infection and therapeutic options. Ann Med 34 (2002) 419-427
36. Athanasopoulos A.N., Economopoulou M., Orlova V.V., et al. The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 107 (2006) 2720-2727
37. Khavari P.A. Therapeutic gene delivery to the skin. Mol Med Today 3 (1997) 533-538
38. Khavari P.A., and Krueger G.G. Cutaneous gene therapy. Dermatol Clin 15 (1997) 27-35
39. Kootstra N.A., and Verma I.M. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43 (2003) 413-439
40. Levine F., and Friedmann T. Gene therapy. Am J Dis Child 147 (1993) 1167-1174
41. Mulligan R.C. The basic science of gene therapy. Science 260 (1993) 926-932
42. Friedmann T. A brief history of gene therapy. Nat Genet 2 (1992) 93-98
43. Morgan J.R., Tompkins R.G., and Yarmushi M.L. Advances in recombinant retroviruses for gene delivery. Adv Drug Deliv Rev 12 (1993) 143-158
44. Le Doux J.M., Landazuri N., Yarmush M.L., et al. Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Hum Gene Ther 12 (2001) 1611-1621
45. Naldini L., Blomer U., Gallay P., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
46. Kuhn U., Terunuma A., Pfutzner W., et al. In vivo assessment of gene delivery to keratinocytes by lentiviral vectors. J Virol 76 (2002) 1496-1504
47. Siprashvili Z., and Khavari P.A. Lentivectors for regulated and reversible cutaneous gene delivery. Mol Ther 9 (2004) 93-100
48. Palmer T.D., Rosman G.J., Osborne W.R., et al. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A 88 (1991) 1330-1334
49. Roemer K., and Friedmann T. Concepts and strategies for human gene therapy. Eur J Biochem 208 (1992) 211-225
50. Challita P.M., and Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A 91 (1994) 2567-2571
51. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348 (2003) 255-256
52. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science 299 (2003) 320
53. Terskikh V.V., and Vasiliev A.V. Cultivation and transplantation of epidermal keratinocytes. Int Rev Cytol 188 (1999) 41-72
54. Burt A.M., Pallett C.D., Sloane J.P., et al. Survival of cultured allografts in patients with burns assessed with probe specific for Y chromosome. BMJ 298 (1989) 915-917
55. Wilson J.M. Adenoviruses as gene-delivery vehicles. N Engl J Med 334 (1996) 1185-1187
56. Schiedner G., Morral N., Parks R.J., et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18 (1998) 180-183
57. Wang Q., and Finer M.H. Second-generation adenovirus vectors. Nat Med 2 (1996) 714-716
58. Young L.S., Searle P.F., Onion D., et al. Viral gene therapy strategies: from basic science to clinical application. J Pathol 208 (2006) 299-318
59. Kafri T., Morgan D., Krahl T., et al. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci U S A 95 (1998) 11377-11382
60. Monahan P.E., and Samulski R.J. AAV vectors: is clinical success on the horizon?. Gene Ther 7 (2000) 24-30
61. Glorioso J.C., Goins W.F., Schmidt M.C., et al. Engineering herpes simplex virus vectors for human gene therapy. Adv Pharmacol 40 (1997) 103-136
62. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci U S A 93 (1996) 11307-11312
63. Yao F., and Eriksson E. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum Gene Ther 10 (1999) 1811-1818
64. Costantini L.C., Bakowska J.C., Breakefield X.O., et al. Gene therapy in the CNS. Gene Ther 7 (2000) 93-109
65. Felgner P.L., and Rhodes G. Gene therapeutics. Nature 349 (1991) 351-352
66. Ortiz-Urda S., Thyagarajan B., Keene D.R., et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med 8 (2002) 1166-1170
67. Hengge U.R., Chan E.F., Foster R.A., et al. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 10 (1995) 161-166
68. Meuli M., Liu Y., Liggitt D., et al. Efficient gene expression in skin wound sites following local plasmid injection. J Invest Dermatol 116 (2001) 131-135
69. Sawamura D., Yasukawa K., Kodama K., et al. The majority of keratinocytes incorporate intradermally injected plasmid DNA regardless of size but only a small proportion of cells can express the gene product. J Invest Dermatol 118 (2002) 967-971
70. Sun L., Xu L., Chang H., et al. Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 108 (1997) 313-318
71. Ciernik I.F., Krayenbuhl B.H., and Carbone D.P. Puncture-mediated gene transfer to the skin. Hum Gene Ther 7 (1996) 893-899
72. Eriksson E., Yao F., Svensjo T., et al. In vivo gene transfer to skin and wound by microseeding. J Surg Res 78 (1998) 85-91
73. Cheng L., Ziegelhoffer P.R., and Yang N.S. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci U S A 90 (1993) 4455-4459
74. Davidson J.M., Krieg T., and Eming S.A. Particle-mediated gene therapy of wounds. Wound Repair Regen 8 (2000) 452-459
75. Klein R.M., Wolf E.D., Wu R., et al. High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology 24 (1992) 384-386
76. Sun W.H., Burkholder J.K., Sun J., et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci U S A 92 (1995) 2889-2893
77. Williams R.S., Johnston S.A., Riedy M., et al. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 88 (1991) 2726-2730
78. Yang N.S., Burkholder J., Roberts B., et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 87 (1990) 9568-9572
79. Yang N.S., and Sun W.H. Gene gun and other non-viral approaches for cancer gene therapy. Nat Med 1 (1995) 481-483
80. Felgner P.L. Cationic liposome-mediated transfection. Focus 11 (1989) 21-25
81. Li L., and Hoffman R.M. The feasibility of targeted selective gene therapy of the hair follicle. Nat Med 1 (1995) 705-706
82. Trubetskoy V.S., Torchilin V.P., Kennel S., et al. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(l-lysine)-antibody conjugate in mouse lung endothelial cells. Biochim Biophys Acta 1131 (1992) 311-313
83. Carlesso G., Kozlov E., Prokop A., et al. Nanoparticulate system for efficient gene transfer into refractory cell targets. Biomacromolecules 6 (2005) 1185-1192
84. Kaul G., and Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res 22 (2005) 951-961
85. Pison U., Welte T., Giersig M., et al. Nanomedicine for respiratory diseases. Eur J Pharmacol 533 (2006) 341-350
86. Eming S.A., Morgan J.R., and Berger A. Gene therapy for tissue repair: approaches and prospects. Br J Plast Surg 50 (1997) 491-500
87. La Cava A., Billetta R., Gaietta G., et al. Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant. J Immunol 164 (2000) 1340-1345
88. Bonadio J. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev 44 (2000) 185-194
89. Bonadio J., Smiley E., Patil P., et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 (1999) 753-759
90. Doukas J., Chandler L.A., Gonzalez A.M., et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 12 (2001) 783-798
91. Shea L.D., Smiley E., Bonadio J., et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17 (1999) 551-554
92. Gu D.L., Nguyen T., Gonzalez A.M., et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther 9 (2004) 699-711
93. Jaakkola P., Ahonen M., Kahari V.M., et al. Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element. Gene Ther 7 (2000) 1640-1647
94. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89 (1992) 5547-5551
95. Gossen M., Freundlieb S., Bender G., et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268 (1995) 1766-1769
96. No D., Yao T.P., and Evans R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 93 (1996) 3346-3351
97. Wang X.J., Liefer K.M., Tsai S., et al. Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci U S A 96 (1999) 8483-8488
98. Wang Y., O'Malley Jr. B.W., Tsai S.Y., et al. A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A 91 (1994) 8180-8184
99. Rivera V.M., Clackson T., Natesan S., et al. A humanized system for pharmacologic control of gene expression. Nat Med 2 (1996) 1028-1032
100. Liberles S.D., Diver S.T., Austin D.J., et al. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci U S A. 94 (1997) 7825-7830
101. Pfutzner W., Terunuma A., Tock C.L., et al. Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo. Proc Natl Acad Sci U S A 99 (2002) 13096-13101
102. Chandler L.A., Gu D.L., Ma C., et al. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen 8 (2000) 473-479
103. Hengge U.R., Taichman L.B., Kaur P., et al. How realistic is cutaneous gene therapy?. Exp Dermatol 8 (1999) 419-431
104. Krueger G.G., Morgan J.R., Jorgensen C.M., et al. Genetically modified skin to treat disease: potential and limitations. J Invest Dermatol 103 (1994) 76S-84S
105. Eming S.A., Lee J., Snow R.G., et al. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice-implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 105 (1995) 756-763
106. Eming S.A., Snow R.G., Yarmush M.L., et al. Targeted expression of insulin-like growth factor to human keratinocytes: modification of the autocrine control of keratinocyte proliferation. J Invest Dermatol 107 (1996) 113-120
107. Boyce S.T., Goretsky M.J., Greenhalgh D.G., et al. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 222 (1995) 743-752
108. Eming S.A., Medalie D.A., Tompkins R.G., et al. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 9 (1998) 529-539
109. Mesri E.A., Federoff H.J., and Brownlee M. Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ Res 76 (1995) 161-167
110. Breitbart A.S., Grande D.A., Mason J.M., et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 42 (1999) 488-495
111. Machens H.G., Morgan J.R., Berthiaume F., et al. Genetically modified fibroblasts induce angiogenesis in the rat epigastric island flap. Langenbecks Arch Surg 383 (1998) 345-350
112. Andree C., Swain W.F., Page C.P., et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci U S A 91 (1994) 12188-12192
113. Ghazizadeh S., Harrington R., and Taichman L. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Ther 6 (1999) 1267-1275
114. Gruss C.J., Satyamoorthy K., Berking C., et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J Invest Dermatol 120 (2003) 683-692
115. Lou J., Tu Y., Burns M., et al. BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res 19 (2001) 1199-1202
116. Eming S.A., Whitsitt J.S., He L., et al. Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112 (1999) 297-302
117. Benn S.I., Whitsitt J.S., Broadley K.N., et al. Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin. J Clin Invest 98 (1996) 2894-2902
118. Jeschke M.G., Richter G., Herndon D.N., et al. Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent. Gene Ther 8 (2001) 1777-1784
119. Yamasaki K., Edington H.D., McClosky C., et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 101 (1998) 967-971
120. Liechty K.W., Nesbit M., Herlyn M., et al. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 113 (1999) 375-383
121. Ha X., Li Y., Lao M., et al. Effect of human hepatocyte growth factor on promoting wound healing and preventing scar formation by adenovirus-mediated gene transfer. Chin Med J (Engl) 116 (2003) 1029-1033
122. Nakanishi K., Uenoyama M., Tomita N., et al. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the Sendai virus (hemagglutinating virus of Japan). Am J Pathol 161 (2002) 1761-1772
123. Glatzel M., Flechsig E., Navarro B., et al. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 97 (2000) 442-447
124. Zhang F., and Lineaweaver W.C. Gene transfer with DNA strand technique and peripheral nerve injuries. J Long Term Eff Med Implants 12 (2002) 85-96
125. Shy M.E., Tani M., Shi Y.J., et al. An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann Neurol 38 (1995) 429-436
126. Sorensen J., Haase G., Krarup C., et al. Gene transfer to Schwann cells after peripheral nerve injury: a delivery system for therapeutic agents. Ann Neurol 43 (1998) 205-211
127. Sakamoto T., Watabe K., Ohashi T., et al. Adenoviral vector-mediated GDNF gene transfer prevents death of adult facial motoneurons. Neuroreport 11 (2000) 1857-1860
128. Terasaki K., Kanzaki T., Aoki T., et al. Effects of recombinant human tissue inhibitor of metalloproteinases-2 (rh-TIMP-2) on migration of epidermal keratinocytes in vitro and wound healing in vivo. J Dermatol 30 (2003) 165-172
129. Roth D., Piekarek M., Paulsson M., et al. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am J Pathol 168 (2006) 670-684
130. Erdag G., and Morgan J.R. Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 235 (2002) 113-124
131. Elson D.A., Thurston G., Huang L.E., et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 15 (2001) 2520-2532
132. Trentin D., Hall H., Wechsler S., et al. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A 103 (2006) 2506-2511
133. de Crombrugghe B., Lefebvre V., Behringer R.R., et al. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 19 (2000) 389-394
134. Hansen S.L., Myers C.A., Charboneau A., et al. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 163 (2003) 2421-2431
135. Uyeno L.A., Newman-Keagle J.A., Cheung I., et al. Hox D3 expression in normal and impaired wound healing. J Surg Res 100 (2001) 46-56
136. Mace K.A., Hansen S.L., Myers C., et al. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 118 (2005) 2567-2577
137. Shi Y., Reitmaier B., Regenbogen J., et al. CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. Am J Pathol 166 (2005) 303-312
138. Ashcroft G.S., Yang X., Glick A.B., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1 (1999) 260-266
139. Watanabe H., de Caestecker M.P., and Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276 (2001) 14466-14473
140. Sohn Y.D., Lim H.J., Hwang K.C., et al. A novel recombinant basic fibroblast growth factor and its secretion. Biochem Biophys Res Commun 284 (2001) 931-936